Who owns PROTAGENIC THERAPEUTICS INC COM?
- Ticker: PTIX
- CUSIP Number: 74365n301
Tip: Access positions for across all investors
Analyze quarterly positions in Protagenic Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Protagenic Therapeutics stock
Who bought or sold PROTAGENIC THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DRW Holdings | 43k | $56k | 18% | Dec 2025 |
|
| FNY Investment Advisers | 25k | $32k | 43% | Dec 2025 |
|
| Citadel Advisors | 23k | $30k | 100% | Dec 2025 |
|
| Geode Capital Management | 12k | $16k | 100% | Dec 2025 |
|
| Raymond James Financial | 10k | $13k | 100% | Dec 2025 |
|
| Tower Research Capital | 3.0k | $4.0k | 145% | Dec 2025 |
|
| CoreCap Advisors | 100.00 | $68.000000 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 49.00 | $63.998900 | 100% | Dec 2025 |
|
| CWM | 1.00 | $0 | 0% | Dec 2025 |
|
| Harbor Investment Advisory | 1.00 | $1.000000 | 0% | Dec 2025 |
|
Who sold out of Protagenic Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Connective Capital Management | Sep 2025 | 29k | $98k |
| UBS Group | Sep 2025 | 56.00 | $192.001600 |